Effects of methylene blue on postoperative low-back pain and functional outcomes after lumbar open discectomy: a triple-blind, randomized placebo-controlled trial (2015)

Peer-Reviewed Study · Farrokhi MR, Lotfi M, Masoudi MS, et al. · September 11, 2015

Farrokhi MR et al., 2015-09-11: Triple-blind randomized trial of 0.5% methylene blue applied to the dura and surrounding tissues after lumbar discectomy, finding less postoperative low-back pain. The injection is epidural/paraspinal, not intradiscal or intra-articular.

A single dose of MB (1 ml 0.5%) for coating the dura and surrounding tissues (facet and muscle) shows promising results in terms of safety, reduction of postoperative pain, and functional outcome compared with placebo.

Farrokhi MR et al., 2015-09-11: Triple-blind randomized trial of 0.5% methylene blue applied to the dura and surrounding tissues after lumbar discectomy, finding less postoperative low-back pain. The injection is epidural/paraspinal, not intradiscal or intra-articular. Study type: prospective, randomized, triple-blind, placebo-controlled trial. N=115 (56 MB, 59 saline). Country: Iran (Shiraz University of Medical Sciences). MB 1 mL of 0.5% solution (5 mg) applied to dura, facet and muscle; single dose. Funding/conflicts: not stated. Comparator: 1 mL normal saline. Outcomes: VAS 1.25 vs 2.80 at 24 h; 1.02 vs 2.07 at 3 months. Route is the key correction: not into the disc or joint. Study type: randomized trial.